PMID: 15034580

Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O'Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, Pang YP, Alekseev AE, Terzic A
ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.
Nat Genet. 2004 Apr;36(4):382-7. Epub 2004 Mar 21., [PubMed]
Sentences
No. Mutations Sentence Comment
2 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:2:343
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:2:344
status: NEW
view ABCC9 p.Ala1513Thr details
Published online 21 March 2004; doi:10.1038/ng1329 L E T T E R S 382 VOLUME 36 | NUMBER 4 | APRIL 2004 NATURE GENETICS a b 1310 GEIKI...HRVSSIMDAGLVLVFSEGILVECDTVPNLLAHKNGLFSTLVMTNK* 1549 1310 GEIKI...HRVSSIMDAGLVLVFSEGIKCGV* 1527 4570-4572delTTAinsAAAT (Fs1524) 1310 GEIKI...HRVSSIMDTGLVLVFSEGILVECDTVPNLLAHKNGLFSTLVMTNK* 1549 4537G→A (A1513T) ...HRVSSIMDAGLVLVFSEGILVECDTGPNLLQHKNGLFSTLVMTNK* Rat ...HRVSSIVDAGLVLVFSEGILVECDTGPNLLQHKNGLFSTLVMTNK* Mouse ...HRVSSIVDADLVLVFSEGILVECDTGPNLLTHKNGLFSTLVMTNK* Rabbit ...HRVSSITDADLVLVFSEGILVECDTGPNLLTYRNGLFSTLVMTHK* Guinea pig T A G T G T G A G G T G A T T T T A T G G A G T G T G A G G T G T A A A T T A T G G Asp Cys Glu Val Leu Ile Gly Ter Val Gly Cys Lys Ile Gly G A T C G A T C T T G T T C C G G A C A T A G G T A T T A T T G T T C C G G A C G T A G G T A T T A Val Leu Gly Thr Asp Met Ile Val Leu Gly Ala Asp Met Ile G A T C G A T C COOH 3 4 5 0 1 2 3 Individual 2 3 4 5 Absorbance(mV) 0 1 2 3 Frameshift mutationNormal Missense mutationNormal NormalNormal Time (min)Time (min) Absorbance(mV) Human wild-type Individual 1 NBD1 NBD2 Exon 38 SUR2A Kir6.2   Stress tolerance of the heart requires high-fidelity metabolic sensing by ATP-sensitive potassium (KATP) channels that adjust membrane potential-dependent functions to match cellular energetic demand. Login to comment
11 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:11:70
status: NEW
view ABCC9 p.Ala1513Thr details
Sequencing identified frameshift (Fs1524; individual 1) and missense (A1513T; individual 2) mutations. Login to comment
28 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:28:107
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:28:108
status: NEW
view ABCC9 p.Ala1513Thr details
The second mutated allele harbored a missense mutation (4537G→A) causing the amino acid substitution A1513T (Fig. 1a). Login to comment
30 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:30:94
status: NEW
view ABCC9 p.Ala1513Thr details
The C terminus of SUR proteins contributes to KATP channel traf- ficking19,20, and Fs1524 and A1513T SUR2A mutants, reconstituted with Kir6.2, had reduced expression in the plasma membrane (Fig. 2a). Login to comment
34 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:34:15
status: NEW
view ABCC9 p.Ala1513Thr details
(a) Fs1524 and A1513T reduced KATP channel trafficking by ~70% and ~30%, probed immunologically by SUR surface expression in Xenopus laevis oocytes. Login to comment
38 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:38:9
status: NEW
view ABCC9 p.Ala1513Thr details
Missense A1513T (cyan) and frameshift L1524 (magenta) mutations frame the β-strand adjacent to Walker motifs that coordinate NBD2-mediated catalysis. Login to comment
44 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:92
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:94
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:147
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:149
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:376
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:380
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:854
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:44:856
status: NEW
view ABCC9 p.Ala1513Thr details
-6 -5 -4 -3 -2 0.0 0.2 0.4 0.6 0.8 1.0 WT IC50: 19 ± 2µM 0.0 0.1 0.2 0.3 0.4 0.5 WT A1513T Fs1524 a e NBD2 of SUR2A WB WA COOH c WT Fs1524 A1513T 0 30 60 90 b WB WA L1524 A1513 G1514 G1530 V1501 V1342 C1345 L1517 V1518 V1525 E1526 M1472 L1470 d T1502 L1540 E1541 Frameshiftmutation Missense mutation Log[ATP] (M) Singlechannelconductance(pS) Surfaceexpression(a.u.) A1513T IC50: 148 ± 9µM Fs1524 IC50: 51 ± 4µM Relativechannelactivity Table 1 Summary of clinical phenotypes Individual ABCC9 Family history Gender, LVEDD (mm)a EF (%)b Coronary Cardiac rhythmc Outcome mutation of DCM age at diagnosis (y) angiography Individual 1 Frameshift No Male, 55 65 (55) 23 Normal Ventricular Death from (Fs1524) tachycardia heart failure at age 60 y Individual 2 Missense Yes Female, 40 89 (52) 15 Normal Ventricular Under intensive (A1513T) tachycardia therapy Male, 54 81 (53) 13 Normal Ventricular Death from heart Father of individual 2 tachycardia failure at age 55 y aLVEDD, left ventricular end-diastolic dimension. Login to comment
48 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:223
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:224
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:323
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:431
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:435
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:448
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:452
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:493
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:497
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:534
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:48:541
status: NEW
view ABCC9 p.Ala1513Thr details
L E T T E R S 384 VOLUME 36 | NUMBER 4 | APRIL 2004 NATURE GENETICS -20 -10 0 10 20 40 0.1 0.2 0.3 0.4 0.5 0 5 10 15 20 0 2 4 6 NS 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8e d 209 84 40.6 31.9 18.5 WT MBP 84 84 b ATP Pi Blank MBP WT A1513T Fs1524 MBP-NBD2 c f Fluorescence/[TNP-ATP](a.u./µM) Total [TNP-ATP] (µM) WT Fs1524 A1513T Fluorescence (a.u.) ATPaseactivity -1 (min) [ADP] (mM) [ATP] -1 (mM) ATPaseactivity-1(min) WT Fs1524 A1513T WT Fs1524 A1513T Time (min) Anti-MBP Anti-SUR2A Fs1524 A1513T F(a.u.) a [Pi](µM) WT Fs1524 A1513T 0.00 0.0 1.0 2.0 3.0 4.0 0.12 0.10 0.08 0.06 0.04 0.02 0.00 1.00.50.0 0.20 .3.11.00.50.0-0.5-1.0 30 disrupt folding of the C-terminal β-strand and, thus, the tertiary organization of the adjacent second nucleotide binding domain (NBD2) pocket in SUR2A. Login to comment
49 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:49:144
status: NEW
view ABCC9 p.Ala1513Thr details
ATP-induced KATP channel gating was aberrant in both channel mutants (Fig. 2e), suggesting that structural alterations induced by the mutations A1513T and Fs1524 of SUR2A distorted ATP-dependent pore regulation. Login to comment
51 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:51:4
status: NEW
view ABCC9 p.Ala1513Thr details
The A1513T and Fs1524 mutations substantially diminished the maximal rate of the NBD2 ATPase reaction without altering the Michaelis-Menten constant of catalysis (Fig. 3d). Login to comment
52 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:52:0
status: NEW
view ABCC9 p.Ala1513Thr details
A1513T reduced the product-dependent inhibition of the NBD2 ATPase more substantially than Fs1524 (Fig. 3e) but produced a less severe delay in the pre-steady state profile of product accumulation (Fig. 3f). Login to comment
53 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:53:20
status: NEW
view ABCC9 p.Ala1513Thr details
Thus, the mutations A1513T and Fs1524 compromise ATP hydrolysis at SUR2A NBD2, generating distinct reaction kinetic defects. Login to comment
54 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:54:37
status: NEW
view ABCC9 p.Ala1513Thr details
Aberrant catalytic properties in the A1513T and Fs1524 mutants translated into abnormal interconversion of discrete conformations in the NBD2 ATPase cycle (Fig. 4a). Login to comment
58 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:58:17
status: NEW
view ABCC9 p.Ala1513Thr details
In contrast, the A1513T mutation delayed the ATPase cycle in the SUR-ADP conformation, by reducing the rate constant defining ADP dissociation (k4) by a factor of 2, and reduced the ADP association rate constant (k04) by a factor of 10 (Fig. 4a-c). Login to comment
59 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:59:25
status: NEW
view ABCC9 p.Ala1513Thr details
The ATPase cycle in both A1513T and Fs1524 mutants was abnormally delayed in a posthydrolytic conformation, SUR-ADP-Pi or SUR-ADP. Login to comment
62 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:62:91
status: NEW
view ABCC9 p.Ala1513Thr details
Consequently, alterations in hydrolysis-driven SUR2A conformational probability induced by A1513T and Fs1524 translated into abnormal ATP sensitivity of mutant channels (Fig. 2e). Login to comment
65 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:65:54
status: NEW
view ABCC9 p.Ala1513Thr details
Compared to the wild type and at any given ATP level, A1513T and Fs1524 mutants were less responsive in ADP-induced redistribution of post- (Fig. 4e) and prehydrolytic (Fig. 4f) conformations. Login to comment
68 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:68:20
status: NEW
view ABCC9 p.Ala1513Thr details
Thus, the mutations A1513T and Figure 3 SUR2A NBD2 mutants have normal ATP binding but altered ATPase properties. Login to comment
70 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:70:87
status: NEW
view ABCC9 p.Ala1513Thr details
An antibody against the last 12 amino acids of SUR2A recognized the wild-type (WT) and A1513T mutant but not Fs1524, whereas an antibody raised against MBP reacted with all constructs. Login to comment
74 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:74:8
status: NEW
view ABCC9 p.Ala1513Thr details
(c) The A1513T and Fs1524 NBD2 mutations reduced ATPase activity measured from γ-32P liberation after [γ-32P]ATP hydrolysis. Login to comment
76 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:76:173
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:76:175
status: NEW
view ABCC9 p.Ala1513Thr details
(d,e) ATP and ADP dependence of NBD2 ATPase activities measured by spectrophotometry showed vmax values of 9.98 ± 0.34 min-1 in wild-type (WT), 6.07 ± 0.18 min-1 in A1513T and 5.69 ± 0.29 min-1 in Fs1524 with Michaelis-Menten constants at 0.11 ± 0.02, 0.094 ± 0.013 and 0.084 ± 0.010 mM, respectively (equation 3). Login to comment
78 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:78:200
status: NEW
view ABCC9 p.Ala1513Thr details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:78:204
status: NEW
view ABCC9 p.Ala1513Thr details
ADP-dependent inhibition of the NBD2 ATPase (at 2 mM ATP) was characterized by an ADP-dissociation constant (KADP) of 8.6 ± 0.3 µM in wild-type versus 24.9 ± 5.6 and 11.0 ± 1.5 in the A1513T and Fs1524 mutants, respectively (equation 5). Login to comment
79 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:79:74
status: NEW
view ABCC9 p.Ala1513Thr details
(f) Both pre-steady state and steady-state reaction rates were altered by A1513T and Fs1524 mutations in stopped-flow experiments. Login to comment
104 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:104:160
status: NEW
view ABCC9 p.Ala1513Thr details
(c) Rate-limiting steps in the SUR2A ATPase cycle are ADP dissociation (k4) for wild-type (WT), Pi dissociation (k3) for Fs1524 and abnormally increased k4 for A1513T. Login to comment
111 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:111:16
status: NEW
view ABCC9 p.Ala1513Thr details
Both Fs1524 and A1513T diminished the ADP-responsiveness of PΣADP and PE-ATP. Login to comment
113 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:113:141
status: NEW
view ABCC9 p.Ala1513Thr details
(g) ADP-scavenging creatine kinase (0.01 U ml-1, 5 mM creatine phosphate) accelerates the ATPase in the wild type (WT) but not in Fs1524 and A1513T mutants. Login to comment
115 ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 15034580:115:181
status: NEW
view ABCC9 p.Ala1513Thr details
(h,i) After coexpression of Kir6.2, channel activity, at 0.3 mM ATP, in the presence and absence of 0.3 mM ADP was measured in wild-type (WT; n = 5) SUR2A and in Fs1524 (n = 4) and A1513T (n = 6) SUR2A mutants in inside-out patches. Login to comment